AnPac Bio-Medical Science Co. Ltd. (ANPC)

Market Cap	5.54M
Revenue (ttm)	2.78M
Net Income (ttm)	-16.30M
Shares Out	39.26M
EPS (ttm)	-1.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	312,272
Open	0.148
Previous Close	0.148
Day's Range	0.141 - 0.164
52-Week Range	0.130 - 3.534
Beta	1.30
Analysts	Buy
Price Target	8.16 (+5,679.0%)
Earnings Date	Sep 29, 2022

About ANPC

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

• Industry: Biotechnology
• IPO Date: Jan 30, 2020
• Employees: 89
• Stock Exchange: NASDAQ
• Ticker Symbol: ANPC

Full Company Profile

Financial Performance

In 2021, ANPC's revenue was 17.99 million, a decrease of -12.30% compared to the previous year's 20.51 million. Losses were -118.70 million, 47.5% more than in 2020.

Financial numbers in CNY Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for ANPC stock is "Buy." The 12-month stock price forecast is 8.16, which is an increase of 5,679.04% from the latest price.

Price Target

$8.16

(5,679.04% upside)

Analyst Consensus: Buy

Stock Forecasts